Immatics NV (IMTX) earnings

Healthcare · Biotechnology · Market cap $1.1B

In the quarter ended June 2025, Immatics NV had revenue of —, and diluted EPS of -0.58.

On August 18, 2026 it reported EPS of -0.53 against an estimate of -0.43 (missed).

The next report is expected on Monday, November 16, 2026, with EPS expected around -0.50.

Report dates

ReportDateTimeEPS estimateEPS reported
NextMon Nov 16, 2026 — -0.50 —
LastTue Aug 18, 2026 — -0.43 -0.53

Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.

Quarterly results

The last 9 quarters from Immatics NV's 10-Q and 10-K filings with the SEC, in EUR. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.

Quarter endedRevenueGrowthEPS (diluted)GrowthOp. marginFiled
Jun 30, 2025— — -0.58 — — 2025-08-13
Dec 31, 2024— — — — — 2025-03-27
Sep 30, 2024— — -0.08 — — 2025-03-27
Jun 30, 2024— — -0.17 — — 2024-08-13
Mar 31, 2024— — -0.03 — — 2025-03-27
Jun 30, 2023— — -0.32 — — 2023-08-17
Jun 30, 2022— — -0.22 — — 2022-08-09
Jun 30, 2021— — -0.42 — — 2021-08-10
Jun 30, 2020— — — — — 2021-08-10
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for IMTX.
Open IMTX in Investingly

Questions

When does Immatics NV report earnings?

Immatics NV's next earnings report is expected on November 16, 2026.

How did Immatics NV do last quarter?

In the quarter ended June 2025, Immatics NV had revenue of —, and diluted EPS of -0.58.

From Immatics NV's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.